NIH International Research in Infectious Diseases (R01 clinical trial not alllowed), 2020

Deadline for letter of intent: 15 Jun 2020

Deadline for applications: 15 Jul 2020

Purpose

The purpose of this Funding Opportunity Announcement (FOA) is to invite applications for support of research on infectious diseases in eligible (resource constrained) foreign countries. Applicant organizations must be headquartered in foreign (non-U.S.) resource-constrained countries (i.e. low-income economies, lower-middle-income economies, and upper-middle-income economies by World Bank Classification). Eligibility status of applicant organizations will be determined by this World Bank Classification list at application submission date. Research should focus on infectious diseases, including HIV/AIDS, of interest to the local country and important from a global health perspective. Collaborative projects involving investigators from international sites and the U.S. are particularly encouraged. These grants will serve to build independent research capacity by providing direct funding to investigators who do not currently have NIH-funded grant or contract awards for research projects. The intent of these activities is to advance the development of local scientific expertise.

Background

The NIAID has a long-standing interest in, and commitment to, global health and international research. Topics of interest for this program are limited to research on infectious diseases, including, but not limited to: tuberculosis, malaria, influenza, HIV/AIDS, arboviral encephalitides and other viral diseases, parasitic diseases, vectors and vector-borne diseases, emerging and/or re-emerging infectious diseases, and the development of drug resistance that are of public health significance. Development of basic, immunological, microbiological, biostatistical, epidemiological, data management, and clinical research capacity is encouraged.

Research Objectives and Scope

Studies may be proposed on any aspect of infectious disease research (except clinical trials), including but not limited to: the epidemiology, natural history, pathogenesis, immunopathogenesis of infectious diseases; epidemiologic studies to define the incidence, clinical presentations, and outcomes of diseases; identification of resistance mechanisms and patterns; characterization of susceptible cohorts for a particular pathogen; pilot and feasibility studies in preparation for larger studies.

Collaborative projects involving investigators and institutions from international sites and the U.S. are particularly encouraged; however, a U.S. partner is not required. NIH supports several international research programs on infectious diseases, including HIV/AIDS. This International Research in Infectious Diseases (IRID) Program is intended to complement these programs by expanding the breadth of research supported at international sites and by providing support to new researchers. This may include sites where NIH or NIAID already has significant investment in research and/or infrastructure. However, previous NIH funding is not a requirement.

Applicants are encouraged to establish multi-institutional collaborations and to include activities that involve the transfer of technologies and research methods, sharing of core resources including the administration of research grant programs, and expansion of linkages to other sites via attendance at national and international meetings and other methods of communication.

Note: Clinical trials will not be supported. When non-interventional clinical studies using human subjects are an element of the research proposed, NIAID policy requires that studies be monitored commensurate with the degree of potential risk to study subjects and the complexity of the study

To find out more, or to apply, visit the call webpage.